Factor IX activation by factor XIa proceeds without release of a free intermediate

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• Factor IX activation is a critical step in the blood coagulation cascade.
• The prevailing model suggests activation occurs via a singly-cleaved free intermediate, Factor IX alpha.
• Understanding the precise mechanism is crucial for comprehending hemostasis and thrombosis.

Purpose of the Study:

• To investigate the mechanism of Factor IX activation by Factor XIa.
• To determine whether a free intermediate (Factor IX alpha) is obligatory during activation.
• To differentiate between a sequential cleavage mechanism and a processive mechanism.

Main Methods:

• Enzymatic assays using varying substrate-to-enzyme ratios of Factor IX and Factor XIa.
• Kinetic analysis of cleavage rates for Factor IX zymogen, Factor IX alpha, and Factor IXa alpha.
• Time-course analysis of intermediate and product formation under different reaction conditions.

Main Results:

• No intermediate (Factor IX alpha) was detected at low substrate-to-enzyme ratios.
• Cleavage rate constants for Factor IX zymogen, Factor IX alpha, and Factor IXa alpha were similar.
• Intermediate formation at high substrate-to-enzyme ratios was inconsistent with an obligate intermediate mechanism, supporting a processive model with occasional failure.

Conclusions:

• Factor XIa-catalyzed activation of Factor IX proceeds via a processive mechanism.
• A free intermediate (Factor IX alpha) is not obligately released during this activation.
• Observed intermediates likely result from occasional failures of the processive mechanism.